Sevaro - About the company
Sevaro is a series B company based in Philadelphia (United States), founded in 2013. It operates as a Provider of telemedicine and consulting services for the healthcare sector. Sevaro has raised $50M in funding from Intermountain Healthcare and Valtruis. The company has 58 active competitors, including 11 funded and 2 that have exited. Its top competitors include companies like Rune Labs, BIOS and Aleva Neuro.
Company Details
Provider of telemedicine and consulting services for the healthcare sector. The telemedicine company provides custom teleneurology programs that improve patient outcomes. It offers OneCall, which is an intelligent communication system that improves emergent neurological care.
- Website
- sevaro.com
- Social
- Email ID
- *****@sevaro.com
- Phone Number
- +1 **********
Key Metrics
Founded Year
2013
Location
Philadelphia, United States
Stage
Series B
Total Funding
$50M in 2 rounds
Latest Funding Round
Investors
Ranked
2nd among 58 active competitors
Employee Count
149 as on Jun 30, 2026
Legal entities associated with Sevaro
Sevaro is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Sevaro Health Inc CIN: 830880277 , United States, Active | Dec 31, 2012 | - | 28 (As on Dec 31, 2024) | - |
Sign up to download Sevaro's company profile
Sevaro's funding and investors
Sevaro has raised a total funding of $50M over 2 rounds. Its first funding round was on Feb 28, 2023. Its latest funding round was a Series B round on Jun 11, 2025 for $*****. 2 investors participated in its latest round. Sevaro has 4 institutional investors.
Here is the list of recent funding rounds of Sevaro:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jun 11, 2025 | 1388454 | Series B | 5423029 | 4321205 | 8753121 | 3981886 |
Feb 28, 2023 | 4444645 | Series B | 2173391 | 9273594 | 6240860 | 4251441 |
Access funding benchmarks and valuations. Sign up today!View details of Sevaro's funding rounds and investors
Sevaro's founders and board of directors
Founder? Claim ProfileSevaro's employee count trend
Sevaro has 149 employees as of Jun 26. Here is Sevaro's employee count trend over the years:
Uncover Sevaro's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Sevaro's Competitors and alternates
Top competitors of Sevaro include Rune Labs, BIOS and Aleva Neuro. Here is the list of Top 10 competitors of Sevaro, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Rune Labs 2018, San Francisco (United States), Series B | Platform provider for managing therapies | $56.5M | 62/100 | |
2nd |  Sevaro 2013, Philadelphia (United States), Series B | Provider of telemedicine and consulting services for the healthcare sector | $50M | 50/100 | |
3rd |  BIOS 2015, Cambridge (United Kingdom), Series A | Developer of neural interfaces and AI for neural data analysis | $26M | 48/100 | |
4th |  Aleva Neuro 2008, Lausanne (Switzerland), Series E | Develops implantable deep brain stimulation systems that enables therapies for neurological diseases | $57M | 47/100 | |
5th |  Combinostics 2014, Finland, Acquired | AI-powered solutions for the detection and management of neurological disorders | $4.3M | 43/100 | |
6th |  Medical Brain 2017, New York City (United States), Series B | AI-based clinical decision support platform for neurological conditions | $25.9M | - | 38/100 |
7th |  IntraNerve Neuroscience 2007, Colorado Springs (United States), Unfunded | Provider of neurological therapy plan solutions for healthcare organizations | - | - | 36/100 |
8th |  Neurobrave 2018, Be er Sheva (Israel), Seed | Cloud-based neurology disease detection tool for healthcare professionals | - | 34/100 | |
9th |  Nile 2017, Sherman Oaks (United States), Series B | Provider of AI-based epilepsy management tools for patients and providers | $29.3M | 34/100 | |
10th |  Cove Neurosciences 2022, Toronto (Canada), Unfunded | Provider of software platform to accelerate brain data analytics | - | - | 33/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Sevaro's competitors? Click here to see the top ones
Sevaro's Investments and acquisitions
Sevaro has made no investments or acquisitions yet.
Reports related to Sevaro
Here is the latest report on Sevaro's sector:
News related to Sevaro
Media has covered Sevaro for 1 event in last 1 year.
•
Sevaro Health receives $39M for AI-powered virtual neurology & workflow augmentationHIT Consultant•Sep 18, 2025•Sevaro, Intermountain Healthcare, Valtruis, Catalyst Fund and 2 others
•
Sevaro Partners with Rosman Search to Elevate Neurology Services in Hospitals NationwideGlobeNewswire•Oct 08, 2024•Sevaro, RosmanSearch
•
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Sevaro
Explore our recently published companies
- Paykal - Mumbai based, 2019 founded, Unfunded company
- BCN Retail - Japan based, 1981 founded, Unfunded company
- Vistello - Unfunded company
- PV Lumens - Mumbai based, 2012 founded, Unfunded company
- Blast Studio - London based, 2018 founded, Unfunded company
- Milk Road - Toronto based, 2022 founded, Unfunded company
